Consolidate fragmented medical equipment suppliers into a defensible, recurring-revenue platform commanding 6–8x exit multiples in a $40B+ market.
Find Medical Equipment Supplier Platform TargetsThe U.S. DME and home medical equipment market is highly fragmented, with thousands of independent operators generating $1M–$5M in revenue. Most carry DMEPOS accreditation, Medicare provider numbers, and sticky referral networks — making them ideal roll-up targets for healthcare-focused acquirers building scaled regional platforms.
Fragmentation, recurring rental revenue, regulatory barriers to entry, and demographic tailwinds from an aging population create a compelling buy-and-build opportunity. Scale unlocks better supplier pricing, shared compliance infrastructure, and multiple expansion from 3.5–4.5x at acquisition to 6–8x at exit.
Minimum $500K EBITDA
Platform must generate at least $500K in EBITDA with a clear revenue mix weighted toward rental and service contracts rather than one-time equipment sales.
Active DMEPOS Accreditation and Medicare Provider Numbers
All required accreditations, FDA registrations, and Medicare/Medicaid billing numbers must be current, compliant, and structured for post-acquisition transferability.
Diversified Referral and Customer Base
No single hospital, physician group, or payer should exceed 20–25% of revenue, ensuring the platform is insulated from single-relationship attrition risk.
Tenured Management Team
An operational management layer capable of running daily billing, logistics, and compliance functions independently of the founding owner is non-negotiable.
Geographic Adjacency
Target add-ons within the platform's existing service region to enable shared delivery infrastructure, driver routing optimization, and consolidated warehouse operations.
Complementary Product Categories
Prioritize suppliers offering respiratory therapy, home infusion, or mobility equipment categories not yet in the platform's portfolio to expand wallet share per referral source.
Minimum $300K EBITDA
Add-ons should demonstrate at least $300K in EBITDA with defensible recurring revenue, clean billing history, and no pending Medicare or Medicaid audit exposure.
Transferable Supplier Agreements
Distribution and supplier contracts with national medical brands must include transferability clauses or documented consent pathways to protect revenue continuity post-close.
Build your Medical Equipment Supplier roll-up
DealFlow OS surfaces off-market Medical Equipment Supplier targets with seller signals — the foundation of every successful roll-up.
Shared Compliance and Billing Infrastructure
Centralizing Medicare/Medicaid billing, accreditation management, and audit response across acquired entities reduces overhead and eliminates redundant compliance staffing costs.
Supplier Consolidation and Volume Pricing
Aggregating purchasing across multiple acquired locations unlocks preferred pricing tiers and exclusivity terms from national device manufacturers and distributors.
Referral Network Densification
Cross-selling across a unified referral network of hospitals, discharge planners, and physician groups increases revenue per relationship without adding significant marketing spend.
Revenue Mix Optimization
Systematically converting one-time equipment sales customers to rental and service contracts improves recurring revenue percentage, EBITDA quality, and exit valuation multiples.
A consolidated DME platform with $3M–$5M in EBITDA, weighted toward recurring rental revenue, active DMEPOS accreditation, and a diversified multi-state referral base is positioned to attract regional health system acquirers or healthcare-focused PE sponsors at 6–8x EBITDA — representing a 2–3x multiple arbitrage on add-on acquisitions completed at 3.5–4.5x.
Most successful roll-ups combine one platform acquisition at $500K+ EBITDA with three to five add-ons, targeting a combined $3M–$5M EBITDA before pursuing a strategic exit.
Inheriting undisclosed Medicare or Medicaid billing violations from add-on targets. Rigorous pre-close billing compliance audits and representation and warranty insurance are essential protections.
SBA 7(a) loans are eligible for individual DME acquisitions, typically covering the platform acquisition with 10–20% equity injection, though subsequent add-ons often require alternative financing structures.
CMS competitive bidding rate reductions compress margins and suppress multiples. Platforms with diversified private-pay and commercial insurance revenue alongside Medicare are significantly more attractive to exit buyers.
More Medical Equipment Supplier Guides
DealFlow OS surfaces off-market platform targets with seller motivation scores. Free to join.
Find platform targets — freeNo credit card required
For Buyers
For Sellers